Sex differences in characteristics and outcomes after TAVR-in-TAVR: the PANDORA international registry
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Abstract Background As transcatheter aortic valve replacement (TAVR) expands to younger populations with longer life expectancies, a substantial number will require redo-TAVR procedures. Purpose Comprehensive data on sex-specific clinical characteristics and outcomes following redo-TAVR remain scarce. Methods Patients undergoing redo-TAVR were enrolled in the multicenter PANDORA registry from 19 European centers between 2011 and 2024. Patients were stratified according to sex, and outcomes were assessed using Valve Academic Research Consortium 3 (VARC-3) criteria. The primary endpoint was a composite of all-cause mortality, heart failure hospitalization or aortic valve reintervention. Results Out of more than 30,000 TAVR procedures, 172 patients (median age 80 [IQR: 76-85] years; 76 females [44%], 96 males [56%]) underwent redo-TAVR. Females had fewer prior pacemaker (21.3% vs. 38.5%, p=0.025), and lower baseline creatinine levels (0.9 vs. 1.3 mg/dL, p
Fields of Study & Subjects
Cardiac Valve Diseases and Treatments
Aortic Disease and Treatment Approaches
Infective Endocarditis Diagnosis and Management
Publication details
- Journal / source
- European Heart Journal Supplements
- Volume
- 28
- Issue
- Supplement_3
- Publication date
- 1 March 2026
- Language
- EN